Drugs / Immulina
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05556967 | Aug → Oct 2023 | — | University of Mississippi Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immulina | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05556967 ↗ |
| Route | Oral | “4-200 mg capsules given by mouth once on the only study visit day” NCT05556967 ↗ |